TCM
TMO icon

Teza Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Teza Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,259
Closed -$3.87M – 705
2024
Q3 		$3.87M Sell
6,259
-7,551
-55% -$4.47M 0.42% 58
2024
Q2 		$7.64M Buy
13,810
+13,371
+3,046% +$7.66M 0.94% 12
2024
Q1 		$255K Sell
439
-2,704
-86% -$1.52M 0.03% 471
2023
Q4 		$1.67M Buy
+3,143
New +$1.52M 0.28% 107
2023
Q2 		– Sell
-1,524
Closed -$878K – 719
2023
Q1 		$878K Buy
1,524
+590
+63% +$333K 0.19% 165
2022
Q4 		$514K Sell
934
-3,699
-80% -$1.96M 0.1% 320
2022
Q3 		$2.35M Buy
4,633
+3,658
+375% +$2.05M 0.49% 42
2022
Q2 		$530K Buy
975
+571
+141% +$314K 0.2% 182
2022
Q1 		$239K Sell
404
-1,101
-73% -$632K 0.09% 336
2021
Q4 		$1M Buy
1,505
+6
+0.4% +$3.75K 0.27% 113
2021
Q3 		$856K Sell
1,499
-1,622
-52% -$890K 0.41% 67
2021
Q2 		$1.57M Buy
+3,121
New +$1.47M 0.26% 119
2020
Q4 		– Sell
-980
Closed -$433K – 431
2020
Q3 		$433K Buy
+980
New +$405K 0.25% 130
2019
Q3 		– Sell
-2,092
Closed -$614K – 613
2019
Q2 		$614K Buy
+2,092
New +$576K 0.36% 87
2018
Q1 		– Sell
-2,833
Closed -$538K – 492
2017
Q4 		$538K Buy
+2,833
New +$543K 0.32% 139
2017
Q2 		– Sell
-17,230
Closed -$2.65M – 343
2017
Q1 		$2.65M Buy
17,230
+15,160
+732% +$2.32M 0.77% 13
2016
Q4 		$292K Buy
+2,070
New +$305K 0.41% 84

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Teza Capital Management's TMO Position: Q4 2024 in Review

Teza Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 6,259 shares — an estimated $3.87M sold.

Teza Capital Management first reported a position in TMO in Q4 2016 and held it in 17 quarters. The position peaked at $7.64M in Q2 2024. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Teza Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Teza Capital Management sold 6,259 Thermo Fisher Scientific shares in Q4 2024, an estimated $3.87M.
  • Teza Capital Management first reported a position in Thermo Fisher Scientific in Q4 2016 and held it in 17 quarters.
  • Teza Capital Management's Thermo Fisher Scientific position peaked at $7.64M in Q2 2024.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Teza Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.